1 completed, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Metatropic dwarfism: new trials by email Literature Review of Metatropic dwarfism trials Research Report on Metatropic dwarfism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue Everolimus - Neuroendocrine Tumors | Phase 1 / Phase 2 | Unknown | King Faisal Specialist Hospital & Research Center | 30 | 2012-12-01 | 2018-08-14 |
| Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC) Cilengitide, Cetuximab, Cisplatin - Carcinoma, Non-Small-Cell Lung | Phase 2 | Completed | Merck KGaA, Darmstadt, Germany | 232 | 2009-02-01 | 2017-01-13 |
Carcinoma, Non-Small-Cell Lung (1) · Neuroendocrine Tumors (1)
Neoplasms (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neuroectodermal Tumors (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Cetuximab (1) · Cilengitide (1) · Cisplatin (1) · Drug Therapy (1) · Everolimus (1) · Gemcitabine (1) · Vinorelbine (1)
King Faisal Specialist Hospital & Research Center (1) · Merck KGaA, Darmstadt, Germany (1)
Belgium (1) · Czechia (1) · France (1) · Germany (1) · Ireland (1) · Italy (1) · Poland (1) · Saudi Arabia (1) · Spain (1)
Ali Aljubran, MD (1) · Fazal Hussain, MD (1)